Head Portfolio Ideation and Therapy Strategy
Prefer a full account with a password? Sign Up to Apply
Job Description
Role Purpose
Lead enterprise portfolio choices BD-led asset selection and , strategy by translating long-term ambition into executable priorities, identifying differentiated opportunities and ensuring disciplined delivery through launch and value realization.
Role Profile
• Reports to: Head - Portfolio and Strategy, India Business
• Team size: 4–5 team members
• Stakeholder ecosystem: Biologics (Clinico-Regulatory), India Business Cluster Heads, CEO - India Business, Business Development and Finance
A. Portfolio
Team Leadership & Therapy-Area Ownership
• Lead and develop portfolio team members assigned to defined therapy areas, ensuring clear ownership of Disease Area strategy, opportunity identification, asset evaluation, prioritization and portfolio progression.
TA Strategy & Portfolio Gap Definition
• Lead Disease Area refreshes and translate unmet needs, evolving standards of care and treatment changes into portfolio priorities.
• Define therapy-area aspirations, ideation gaps and indication-expansion opportunities.
Asset Evaluation & Prioritization
• Assess clinical differentiation, patient opportunity, commercial fit, competition, patents, FTO and exclusivity.
• Prioritize assets and maintain a balanced roadmap of high-value opportunities.
BD / In-Licensing Route Strategy
• Compare BD, in-house and third-party routes based on value, complexity, cost, timeline, supply control and exclusivity.
• Recommend preferred and contingency routes with clear rationale and switch triggers.
BD Partnering & Opportunity Enablement
• Enable partner mapping, competitive assessment, diligence and investment rationale for active pursuits.
• Provide differentiated alternatives and maintain decision cases for priority opportunities.
BD Asset Selection & Clinico-Regulatory Strategy
• Map opportunities to divisions and co-create clinico-regulatory strategy for innovative and BD assets.
• Lead cross-functional diligence through NBTS and track selection, signing and closure conditions.
Competitive Intelligence & Strategic Watchlist
• Monitor regulatory, clinical, patent and competitor developments and maintain the asset watchlist.
• Convert intelligence into timely changes in priority, route, forecast, timing and risk mitigation.
Portfolio & New-Product Program Governance
• Govern selected assets across development, registration, sourcing, supply and launch readiness.
• Track execution dependencies, risks, decisions and actions through closure.
B. Strategy
Team Leadership & Strategy Partnering
• Lead, develop and deploy a team of Strategy Business Partners to support business units and therapy areas in strategic planning, execution governance, performance reviews and delivery of priority initiatives.
Strategy Planning & Long-Term Aspiration
• Lead annual and multi-year strategic planning, translating enterprise, cluster and therapy-area ambition into integrated value, volume and business priorities.
• Align top-down aspirations with bottom-up market, brand and functional inputs; define guardrails for resource allocation, sequencing and trade-offs.
Growth Strategy & Strategic Initiatives
• Identify new growth spaces, therapy areas, channels, markets, partnerships and business models.
• Build business cases and Go / No-Go recommendations; pilot and scale approved concepts with clear success and exit criteria.
Market Intelligence, Foresight & Scenario Planning
• Develop market forecasts, strategic scenarios and early-warning indicators; test plan resilience under alternative futures.
Brand Performance, RCA & Countermeasures
• Identify underperforming or strategically critical brands using market, performance, execution and capability indicators.
• Lead cross-functional root-cause analysis and govern countermeasures across Commercial, Medical, Supply and enabling functions.
Strategic Execution & Performance Management
• Convert strategic moves into projects and SDPs with clear scope, ownership, outcomes and cross-functional dependencies.
• Track milestones, risks, course correction and benefits realization, including central productivity and leadership priorities.
Business Governance, PMO & Annual Planning
• Own leadership-review governance, brand and portfolio planning, budgeting alignment and execution readiness.
• Convert approved priorities into initiatives, milestones, KPIs and dependencies; program-manage delivery through benefit realization and closure.
Cluster Priority & New-Product Governance
• Program-manage cluster priorities, including M&A; opportunities and new launches, through an integrated cross-functional PMO.
• Own new-product governance across opportunity, forecast, investment, readiness, execution, post-launch recalibration and learning.
Key Outcomes
• Integrated long-term strategy translated into executable priorities.
• Disciplined delivery of strategic initiatives and growth programs.
• Prioritized, risk-mitigated portfolio with clear BD routes and partner options.
• Selected assets governed through diligence, development and launch readiness.
• Market and competitive intelligence converted into timely strategic and portfolio actions.
Requirements
Function: Other
Experience Level: Mid-Senior Level